3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
5
Phase 2
5
Phase NA
1
Phase 4
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
70
Gastrointestinal
8
Head & Neck
6
Gynecologic
6
Genitourinary
5
Dermatologic
5
Lymphoid
3
CNS
3
Breast
3
Other hematologic neoplasm
2
Other
2
Sarcoma
1
NET
1
Endocrine
1
Classical hematology
1
Conditions
Anemia
30
Neoplasms
21
Febrile Neutropenia
19
Venous Thromboembolism
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Neutropenia
5
Leukemia, Myeloid, Acute
5
Colorectal Neoplasms
5
Pulmonary Embolism
4
Myelodysplastic Syndromes
4
Leukemia
4
Fever
4
Anemia, Iron-Deficiency
4
Venous Thrombosis
3
Thrombocytopenia
3
Ovarian Neoplasms
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Hematologic Neoplasms
3
Breast Neoplasms
3
Adenocarcinoma
3
Vitamin D Deficiency
2
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sepsis
2
Recurrence
2
Postoperative Complications
2
Lymphoma, Follicular
2
Lymphoma
2
Infections
2
Interventions
sotorasib
1
Rivaroxaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lung Neoplasms
×
Classical hematology
×
Clear all
NCT06314763
2024-04-30
ROSIE
Radboud University Medical Center
Phase 4
Completed
21 enrolled